This Rollins Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday
Avi Kapoor 3 months ago
Trading IdeasPre-Market OutlookNewsAnalyst RatingsDowngrades
Top Wall Street analysts changed outlook on top names. See all rating changes on our analyst ratings page. ROL downgraded and price target cut.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Keefe, Bruyette & Woods analyst Catherine Mealor downgraded WesBanco Inc (NASDAQ:WSBC) from Outperform to Market Perform and maintained the price target of $42. Wesbanco shares closed at $40.91 on Wednesday. See how other analysts view this stock.
- Evercore ISI Group analyst John Pancari downgraded Zions Bancorporation (NASDAQ:ZION) from In-Line to Underperform and cut the price target from $74 to $68. Zions Bancorp shares closed at $70.07 on Wednesday. See how other analysts view this stock.
- B of A Securities analyst Curtis Nagle downgraded Rollins Inc (NYSE:ROL) from Buy to Underperform and cut the price target from $55 to $35. Rollins shares closed at $43.47 on Wednesday. See how other analysts view this stock.
- Keybanc analyst Devin Au downgraded Pegasystems Inc (NASDAQ:PEGA) from Overweight to Sector Weight. Pegasystems shares closed at $25.99 on Wednesday. See how other analysts view this stock.
- Citigroup analyst Daniel Grosslight downgraded Agilon Health Inc (NYSE:AGL) from Neutral to Sell and raised the price target from $80 to $105. Agilon Health shares closed at $119.88 on Wednesday. See how other analysts view this stock.
Considering buying ROL stock? Here’s what analysts think:

Photo via Shutterstock